New Insights into Adjuvant Therapy for Localized Colon Cancer

被引：2
作者：
Saoudi Gonzalez, Nadia [1 ]
Ros Montana, Francisco Javier [1 ,2 ]
Garcia Illescas, David [1 ]
Baraibar Argota, Iosune [1 ]
Salva Ballabrera, Francesc [1 ]
Elez Fernandez, Ma Elena [1 ]
机构：
[1] Vall dHebron Univ Hosp, Dept Med Oncol, Passeig Vall dHebron 119, Barcelona 08035, Catalunya, Spain
[2] Univ Campania Luigi Vanvitelli, Med, Caserta, Campania, Italy
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2022年 / 36卷 / 03期
关键词：
Adjuvant treatment; Colon cancer; liquid biopsy; ctDNA; Immunoscore; CIRCULATING-TUMOR DNA; PHASE-III TRIAL; STAGE-II; COLORECTAL-CANCER; SURVIVAL; CHEMOTHERAPY; OXALIPLATIN; LEUCOVORIN; FLUOROURACIL; BEVACIZUMAB;
D O I：
10.1016/j.hoc.2022.02.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：507 / 520
页数：14
相关论文
共 50 条
  • [41] National Landscape of Neoadjuvant Therapy in Potentially Resectable Colon Cancer
    McGough, Daniel P.
    Price, Adam D.
    Whitrock, Jenna N.
    Hariri, Hussein
    Patel, Sameer H.
    Ahmad, Syed A.
    Wilson, Gregory C.
    JOURNAL OF SURGICAL RESEARCH, 2024, 302 : 611 - 620
  • [42] Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for Stage II/III Colon Cancer in a Group at High Risk of Recurrence in Retrospective Study
    Osawa, Hiroshi
    Handa, Naoko
    Minakata, Kunihiko
    ONCOLOGY RESEARCH, 2015, 22 (5-6) : 325 - 331
  • [43] Use of Molecular Biomarkers to Inform Adjuvant Therapy for Colon Cancer
    Mettu, Niharika B.
    Hurwitz, Herbert
    Hsu, David S.
    ONCOLOGY-NEW YORK, 2013, 27 (08): : 746 - 754
  • [44] Adjuvant Chemotherapy of Locally Advanced Colon Cancer: Final Results of a Randomized Trial Comparing 5-Fluorouracil and Folinic Acid with Folfiri
    Paschke, Stephan
    Hebart, Holger
    Goeb, Roland
    Staib, Ludger
    Fleck, Ullrich
    Henne-Bruns, Doris
    Sander, Silvia
    Link, Karl-Heinrich
    Kornmann, Marko
    VISCERAL MEDICINE, 2019, 35 (02) : 124 - 132
  • [45] Neoadjuvant and adjuvant Therapy of resectable Colon Carcinoma: Current Standards and Developments
    Heinemann, Volker
    Stintzing, Sebastian
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (22) : 1457 - 1467
  • [46] Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer
    Kadakia, Kunal C.
    Worrilow, William M.
    Coley, Harris
    Salem, Mohammed E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 289 - 298
  • [47] Oxaliplatin As Part of Adjuvant Therapy for Colon Cancer: More Complicated Than Once Thought
    Mayer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27) : 3325 - 3327
  • [48] Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
    Tie, Jeanne
    Cohen, Joshua D.
    Lahouel, Kamel
    Lo, Serigne N.
    Wang, Yuxuan
    Kosmider, Suzanne
    Wong, Rachel
    Shapiro, Jeremy
    Lee, Margaret
    Harris, Sam
    Khattak, Adnan
    Burge, Matthew
    Harris, Marion
    Lynam, James
    Nott, Louise
    Day, Fiona
    Hayes, Theresa
    McLachlan, Sue-Anne
    Lee, Belinda
    Ptak, Janine
    Silliman, Natalie
    Dobbyn, Lisa
    Popoli, Maria
    Hruban, Ralph
    Lennon, Anne Marie
    Papadopoulos, Nicholas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Tomasetti, Cristian
    Gibbs, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24) : 2261 - 2272
  • [49] Adjuvant therapy for colon cancer
    Cilley J.
    Mulcahy M.F.
    Current Oncology Reports, 2006, 8 (3) : 161 - 166
  • [50] Adjuvant therapy for colon cancer
    Aranha O.
    Benson III A.B.
    Current Gastroenterology Reports, 2007, 9 (5) : 415 - 421
12345